Approval · Notice of Compliance 2323 · 2001
REBIF: Notice of Compliance 2323
Issued December 17, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2323
- Date
- December 17, 2001
- Company
- Serono Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Facility changes
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REBIF | Not yet assigned | — |
Medicinal ingredients
- INTERFERON BETA-1A 22 MCG per SYR
- INTERFERON BETA-1A 11 MCG per VIAL
- INTERFERON BETA-1A 44 MCG per VIAL
- INTERFERON BETA-1A 44 MCG per SYR